TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Uroderma AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
7,116
|
7,863
|
7,125 |
| Financial expenses |
1
|
10
|
3 |
| Earnings before taxes |
3,025
|
3,703
|
3,647 |
| EBITDA |
3,110
|
3,843
|
3,803 |
| Total assets |
7,124
|
6,886
|
6,561 |
| Current assets |
3,424
|
2,957
|
3,047 |
| Current liabilities |
591
|
571
|
1,207 |
| Equity capital |
6,533
|
6,315
|
5,355 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
5
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.7%
|
91.7%
|
81.6% |
| Turnover per employee |
1,423
|
2,621
|
2,375 |
| Profit as a percentage of turnover |
42.5%
|
47.1%
|
51.2% |
| Return on assets (ROA) |
42.5%
|
53.9%
|
55.6% |
| Current ratio |
579.4%
|
517.9%
|
252.4% |
| Return on equity (ROE) |
46.3%
|
58.6%
|
68.1% |
| Change turnover |
-486
|
701
|
1,044 |
| Change turnover % |
-6%
|
10%
|
17% |
| Chg. No. of employees |
2
|
0
|
0 |
| Chg. No. of employees % |
67%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.